Autologous tumor cell vaccination combined with systemic CpG-B and IFN- promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial
Author(s):
Koster, B.D.; Santegoets, S.J.A.M.; Harting, J.; Baars, A.; Ham, S.M. van; Scheper, R.J.; Hooijberg, E.; Gruijl, T.D. de; Eertwegh, A.J.M. van den
Published
2019
Publication type
Article / Letter to editor
Date issued
2019-06-01
Language
English
Publisher
SPRINGER
Is part of
Cancer Immunology, Immunotherapy (2019), Vol. 68, no. 6, p. 1025-1035
